Get the Stockscreener App
7.20
0.83%
-0.06
After Hours:
7.20
Teladoc Health Inc stock is traded at $7.20, with a volume of 2.39M.
It is down -0.83% in the last 24 hours and down -16.67% over the past month.
See More
Previous Close:
$7.26
Open:
$7.19
24h Volume:
2.39M
Relative Volume:
0.32
Market Cap:
$1.14B
Revenue:
$2.59B
Net Income/Loss:
$-981.73M
P/E Ratio:
-1.2478
EPS:
-5.77
Net Cash Flow:
$206.95M
1W Performance:
+5.42%
1M Performance:
-16.67%
6M Performance:
-15.99%
1Y Performance:
-45.99%
1-Day Range:
$7.06
$7.265
1-Week Range:
$6.35
$7.365
52-Week Range:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
2 MANHATTANVILLE ROAD, PURCHASE, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.20 | 1.14B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
227.54 | 34.18B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
56.65 | 9.62B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
52.90 | 7.09B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
85.87 | 6.94B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.02 | 6.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Citi Revises Teladoc (TDOC) Price Target Amidst Cautious Outlook - GuruFocus
To Register Unwavering Growth Of Remote Medical Expert - openPR.com
Teladoc Health (NYSE:TDOC) Shares Fall 10% Over The Past Week - Yahoo Finance
Teladoc (TDOC) Experiences Surge in Bullish Option Activity | TDOC Stock News - GuruFocus
Digital Health In The Neurology Market Focusing On A Series - openPR.com
Chronic Disease Management Market Is Booming So Rapidly - openPR.com
U.S. Digital Mental Health Market New Product Development & Latest Trends | Teladoc Health,BetterHelp,Talkspace - openPR.com
Is Teladoc Health (TDOC) the Best Telehealth Stock to Buy Now? - Insider Monkey
Teladoc Health (TDOC) to Announce Q1 2025 Earnings on April 30 - GuruFocus
10 Best Telehealth Stocks to Buy Now - Insider Monkey
Jefferies cuts Teladoc price target to $8, maintains hold rating By Investing.com - Investing.com India
Jefferies cuts Teladoc price target to $8, maintains hold rating - Investing.com
Teladoc stock plunges to 52-week low, hits $6.61 By Investing.com - Investing.com India
Jefferies Lowers Teladoc (TDOC) Price Target Amid Declining Data Trends | TDOC Stock News - GuruFocus
Teladoc stock plunges to 52-week low, hits $6.61 - Investing.com
Emerging Trends in Telemedicine Second Opinion Solutions - openPR.com
Forecasting the Future: Healthcare Convenience Services - openPR.com
Telehealth Market Size to Reach USD 791.04 billion by 2032, Growing at CAGR of 22.9%NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Telestroke Services Market Set to Witness Significant Growth by 2025-2032 | ScienceSoft, SEVARO, Teladoc Health - openPR.com
Teladoc Health to Announce First Quarter 2025 Financial Results - GuruFocus
Teladoc Health to Announce First Quarter 2025 Financial Results | TDOC Stock News - GuruFocus
Teladoc Health Inc. to Release First Quarter 2025 Results on April 30, 2025 - Nasdaq
Virtual Care Leader Teladoc Health Sets Q1 2025 Earnings Release DateKey Details Inside - Stock Titan
Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade) (NYSE:TDOC) - Seeking Alpha
Emerging Trends in Video Consultation Medical Service Market - openPR.com
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it - TradingView
Future Scope of Virtual Healthcare Home Market to Observe - openPR.com
Virtual Care Services Market Projected To Witness Massive - openPR.com
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction - MSN
Teladoc (TDOC) Experiences Increased Option Activity Ahead of Ea - GuruFocus
BofA Revises Teladoc (TDOC) Price Target Amid Weaker Growth and Strategic Initiatives | TDOC Stock News - GuruFocus
Forecasting The Future: 8 Analyst Projections For Teladoc Health - Benzinga
Lobbying Update: $10,000 of TELADOC HEALTH INC. lobbying was just disclosed - Nasdaq
Teladoc Health Launches New Cardiometabolic Health Program - MedCity News
Unparalleled Research on Behavioral Health Telehealth Market - openPR.com
Digital Health Market Projected To Witness Substantial Growth, - openPR.com
Teladoc (TDOC) Stock Moves -0.97%: What You Should Know - Yahoo Finance
Teladoc Health CFO Murthy Mala sells $51,011 in stock By Investing.com - Investing.com South Africa
Teladoc Health CFO Murthy Mala sells $51,011 in stock - Investing.com
Trend Tracker for (TDOC) - news.stocktradersdaily.com
Teladoc unveils virtual care tool for cardiometabolic health - TechTarget
Digital health startup Transcarent takes Accolade private in $621 million deal - CNBC
Teladoc Health Introduces Next Generation Cardiometabolic Health Program - GlobeNewswire
Revolutionary: New Teladoc Health Program Achieves 58% Diabetes Remission Levels - Stock Titan
Teladoc Stock Plummets to 52-Week Low of $6.76 Amid Market Challenges - Investing.com India
Teladoc Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights – TDOC - ACCESS Newswire
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? - AOL.com
Major Player in the Teletherapy Platform Integration Market - openPR.com
Teladoc (TDOC) Gains But Lags Market: What You Should Know - Yahoo Finance
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):